Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome
About
Immune-mediated, non-communicable diseases, such as autoimmune diseases, allergic diseases and asthma, are chronic disorders in which the immune system plays a pivotal role. The World Health Organisation (WHO) has highlighted the seriousness of autoimmunity and its association with exposure to the environment.
EXIMIOUS aims to deliver a new way of assessing the human exposome, i.e. the exposures to environmental factors that one experiences throughout life, and shed light on its association to immune-mediated diseases.
Partners
EXIMIOUS is part of the European Human Exposome Network and brings together 15 partner organisations from 7 European countries.
FAQ
Don’t know what the exposome is?
Want to know more about exposure-related immune diseases?
Curious to know more about what to expect from this project?
Latest news
Insights from the final EXIMIOUS Symposium on Health Risks of Emerging Contaminants: Microplastics and Indoor Air Quality
The EXIMIOUS project hosted its seventh and final symposium titled “Emerging Contaminants: Health Risks Associated with Microplastics and Indoor Air Quality” on 31 October 2024. Conducted online, this event brought together over 50 experts and attendees from across Europe, offering key insights into the human health implications of exposure to microplastics and indoor air pollutants.
Registration is open for the final EXIMIOUS Symposium on emerging contaminants
The final EXIMIOUS Symposium, titled “Emerging contaminants: health risks associated with microplastics and indoor air quality” will take place on 31st October 2024. Register now and join us online at 15:00 – 17:00 (CET) to learn more. Emerging contaminants (ECs) constitute a wide range of chemicals, including flame retardants, perfluorochemicals, pharmaceuticals, microplastics and a wide
EXIMIOUS Project Meeting in Oslo, Norway (05-06 September 2024)
EXIMIOUS Project Meeting in Oslo, Norway (05-06 September 2024) The EXIMIOUS consortium gathered for a their internal General Assembly meeting from 5-6 September 2024 in Oslo, Norway, hosted by the Norwegian Institute of Public Health (NIPH). The event provided a platform for key project updates, in-depth scientific discussions, and preparations for the upcoming review.
Project facts
EXIMIOUS is a 5 year Research and Innovation Action funded by the European Union’s Horizon 2020 programme.
- Concept: introduce a new approach to mapping exposure-induced immune effects by combining exposomics and immunomics in a unique toolbox.
- Budget: 10.8 million Euro
- Duration: 01.01.2020 - 31.12.2024
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874707.
